Related Experiment Video
Updated: Nov 23, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
LncRNA NBR2 inhibits tumorigenesis by regulating autophagy in hepatocellular carcinoma
Jia-Qi Sheng1, Mu-Ru Wang1, Dan Fang1
1Division of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Abstract:
Long noncoding RNAs (lncRNAs) have been identified to play increasingly important roles in tumorigenesis, and they may serve as novel biomarkers for cancer therapy. LncRNA NBR2 (neighbor of BRCA1 gene 2), a novel identified lncRNA, is demonstrated to decrease in several cancers. However, it is still unknown whether lncRNA NBR2 is involved in hepatocellular carcinoma and autophagy. We found that HCC cases with lower NBR2 expression had significantly worse overall survival than those with higher NBR2 expression in advanced patients. And the expression of NBR2 was negatively correlated with the degree of malignancy of HCC cell lines and differentiation of hepatocellular carcinoma. Besides, NBR2 inhibited the proliferation, invasion, and migration of liver cancer cells. We further found that NBR2 repressed cytoprotective autophagy to restrain HCC cell proliferation. Moreover, NBR2 inhibited Beclin 1-dependent autophagy through ERK and JNK pathways. Taken together, NBR2 suppressed autophagy-induced cell proliferation at least partly through ERK and JNK pathways. These data indicated that NBR2 served as a tumor suppressor gene in hepatocellular carcinoma. The current study provides a novel insight and treatment strategy for hepatocellular carcinoma.
Insights
Long noncoding RNA NBR2 (neighbor of BRCA1 gene 2) acts as a tumor suppressor in liver cancer. Lower NBR2 expression correlates with poor survival and advanced disease, suggesting its therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Long noncoding RNAs (lncRNAs) are implicated in tumorigenesis and cancer therapy.
- LncRNA NBR2 expression is reduced in various cancers, but its role in hepatocellular carcinoma (HCC) and autophagy remains unclear.
Purpose of the Study:
- To investigate the role of lncRNA NBR2 in hepatocellular carcinoma (HCC).
- To determine the relationship between NBR2 expression, HCC progression, and autophagy.
Main Methods:
- Analysis of NBR2 expression in HCC patient samples and cell lines.
- Assessment of NBR2's impact on HCC cell proliferation, invasion, and migration.
- Investigation of NBR2's effect on autophagy pathways, including Beclin 1, ERK, and JNK signaling.
Main Results:
- Lower NBR2 expression in HCC patients correlated with significantly worse overall survival, especially in advanced stages.
- NBR2 expression was inversely associated with the malignancy and differentiation of HCC cell lines.
- NBR2 suppressed HCC cell proliferation, invasion, and migration by repressing Beclin 1-dependent autophagy via ERK and JNK pathways.
Conclusions:
- LncRNA NBR2 functions as a tumor suppressor gene in hepatocellular carcinoma.
- NBR2 inhibits autophagy-driven cell proliferation through the ERK and JNK pathways.
- NBR2 represents a potential novel biomarker and therapeutic target for HCC.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
MicroRNAs
The Nucleolus